• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一家大型多医院机构的规模上实现万古霉素耐药粪肠球菌的长期控制:七年经验。

Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.

机构信息

Direction de la Politique Medicale-Directorate of Medical Politics, Assistance Publique-Hopitaux de Paris, Paris, France.

出版信息

Euro Surveill. 2012 Jul 26;17(30):20229.

PMID:22856512
Abstract

Repeated outbreaks of vancomycin-resistant Enterococcus faecium (VRE) occurred between 2004 and 2010 in Assistance Publique--Hôpitaux de Paris (AP-HP), a 23,000-bed multi-hospital institution. From August 2004 to December 2005, the French guidelines for preventing cross-transmission of multiresistant bacteria were applied. Because the number of VRE cases continued to increase, an institutional control programme was implemented from January 2006 onwards: it foresees stopping transfer of VRE and contact patients, separating VRE and contact patients in distinct cohorts, intervention of a central infection control team to support local teams, and quick application of measures as soon as first VRE cases are identified. Between August 2004 and December 2010, 45 VRE outbreaks occurred in 21 of the 38 AP-HP hospitals, comprising 533 cases. Time series analysis showed that the mean number of cases increased by 0.8 cases per month (95% confidence interval (CI): 0.3 to 1.3, p=0.001) before, and decreased by 0.7 cases per month after implementation of the programme (95% CI: -0.9 to -0.5, p<0.001), resulting in a significant trend change of -1.5 cases per month (95% CI: -2.1 to -0.9, p<0.001). The number of cases per outbreak was significantly lower after implementation of the programme. A sustained and coordinated strategy can control emerging bacteria at the level of a large regional multihospital institution.

摘要

2004 年至 2010 年期间,法国巴黎公立医院集团(AP-HP)发生了多次万古霉素耐药肠球菌(VRE)爆发。2004 年 8 月至 2005 年 12 月期间,法国应用了预防多重耐药菌交叉传播的指南。由于 VRE 病例数量持续增加,自 2006 年 1 月起实施了机构控制计划:该计划包括停止 VRE 和接触患者的转移、将 VRE 和接触患者分开在不同的队列中、由中央感染控制团队支持当地团队,以及一旦发现首例 VRE 病例就迅速采取措施。2004 年 8 月至 2010 年 12 月期间,在 38 家 AP-HP 医院中的 21 家医院发生了 45 起 VRE 爆发,共涉及 533 例病例。时间序列分析显示,在实施该计划之前,每月平均病例数增加了 0.8 例(95%置信区间(CI):0.3 至 1.3,p=0.001),实施该计划后每月减少了 0.7 例(95% CI:-0.9 至 -0.5,p<0.001),导致每月趋势变化显著减少 1.5 例(95% CI:-2.1 至 -0.9,p<0.001)。实施该计划后,每起爆发的病例数明显减少。持续协调的策略可以在大型区域性多医院机构层面控制新出现的细菌。

相似文献

1
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.在一家大型多医院机构的规模上实现万古霉素耐药粪肠球菌的长期控制:七年经验。
Euro Surveill. 2012 Jul 26;17(30):20229.
2
Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.法国一家大学医院对耐万古霉素肠球菌暴发的快速控制
J Hosp Infect. 2007 Sep;67(1):42-8. doi: 10.1016/j.jhin.2007.06.009. Epub 2007 Aug 23.
3
[Interventions implemented to control an outbreak of vancomycin-resistant enterococci in a university hospital].[为控制某大学医院耐万古霉素肠球菌暴发而实施的干预措施]
Nephrol Ther. 2009 Jun;5 Suppl 4:S265-71. doi: 10.1016/S1769-7255(09)74557-2.
4
The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital.澳大利亚一家医院中粪肠球菌vanA克隆暴发与耐甲氧西林金黄色葡萄球菌发生率的关系。
J Hosp Infect. 2001 May;48(1):43-54. doi: 10.1053/jhin.2000.0915.
5
Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis.万古霉素耐药肠球菌在一家三甲医院的爆发:主要通过监测培养指导的措施缺乏效果,以及屎肠球菌和粪肠球菌之间的反应差异。
Am J Infect Control. 2010 Jun;38(5):406-9. doi: 10.1016/j.ajic.2009.08.010. Epub 2009 Dec 16.
6
A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.万古霉素耐药粪肠球菌血流感染医院持续性暴发:由 vanB 型粪肠球菌 203 序列型导致。
J Infect Dis. 2010 Oct 15;202(8):1278-86. doi: 10.1086/656319.
7
Difficulties in detection and identification of Enterococcus faecium with low-level inducible resistance to vancomycin, during a hospital outbreak.在一次医院感染暴发期间,检测和鉴定对万古霉素具有低水平诱导性耐药的屎肠球菌存在困难。
Clin Microbiol Infect. 2008 Sep;14(9):853-7. doi: 10.1111/j.1469-0691.2008.02052.x.
8
Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium.基因分型和抢先隔离以控制耐万古霉素屎肠球菌的暴发。
Clin Infect Dis. 2006 Mar 15;42(6):739-46. doi: 10.1086/500322. Epub 2006 Feb 10.
9
Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation.儿科肿瘤病房耐万古霉素屎肠球菌医院感染暴发的控制:定植的危险因素
Eur J Pediatr. 1998 Jan;157(1):20-7. doi: 10.1007/s004310050760.
10
Successful control of vancomycin-resistant Enterococcus faecium nosocomial outbreak in a teaching hospital in China.成功控制中国一家教学医院的万古霉素耐药粪肠球菌医院感染爆发。
Am J Infect Control. 2012 Aug;40(6):568-71. doi: 10.1016/j.ajic.2011.08.004. Epub 2011 Oct 29.

引用本文的文献

1
GG Versus Placebo for Eradication of Vancomycin-Resistant in Intestinal Carriers: A Systematic Review and Meta-Analysis.糖肽类药物与安慰剂用于根除肠道携带者中耐万古霉素菌的比较:一项系统评价和荟萃分析
Microorganisms. 2023 Nov 19;11(11):2804. doi: 10.3390/microorganisms11112804.
2
Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan.日本青森县万古霉素耐药粪肠球菌的医院间传播。
Antimicrob Resist Infect Control. 2022 Jul 23;11(1):99. doi: 10.1186/s13756-022-01136-5.
3
Expansion of Vancomycin-Resistant in an Academic Tertiary Hospital in Southwest Germany: a Large-Scale Whole-Genome-Based Outbreak Investigation.
在德国西南部的一家学术性教学医院中万古霉素耐药的扩展:一项大规模全基因组为基础的暴发调查。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.01978-18. Print 2019 May.
4
Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015.不同控制措施预防产碳青霉烯酶肠杆菌科和耐糖肽肠球菌爆发的效率:2010 年 1 月至 2015 年 12 月法国多医院机构的一项 6 年前瞻性研究。
Euro Surveill. 2018 Feb;23(8). doi: 10.2807/1560-7917.ES.2018.23.8.17-00078.
5
Patient safety work in Sweden: quantitative and qualitative analysis of annual patient safety reports.瑞典的患者安全工作:年度患者安全报告的定量与定性分析
BMC Health Serv Res. 2016 Mar 21;16:98. doi: 10.1186/s12913-016-1350-5.
6
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.在法国实施严格政策以控制高耐药性微生物传播所产生的成本。
BMJ Open. 2016 Jan 29;6(1):e009029. doi: 10.1136/bmjopen-2015-009029.
7
Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.法国对新出现的广泛耐药菌(eXDRO)的控制:对来自286家医疗机构的感染预防人员的一项调查。
Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1615-20. doi: 10.1007/s10096-015-2396-8. Epub 2015 May 10.
8
Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.医院中万古霉素耐药肠球菌传播的控制:流行病学和临床相关性。
Dtsch Arztebl Int. 2013 Oct;110(43):725-31. doi: 10.3238/arztebl.2013.0725. Epub 2013 Oct 25.
9
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.快速检测糖肽类耐药肠球菌:对决策和成本的影响。
Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30. doi: 10.1186/2047-2994-2-30.
10
The complex dynamics of antimicrobial activity in the human gastrointestinal tract.人类胃肠道中抗菌活性的复杂动态变化。
Trans Am Clin Climatol Assoc. 2013;124:123-32.